G1 THERAPEUTICS, INC.
Profile
Company Names
G1 THERAPEUTICS, INC.
G-ZERO THERAPEUTICS, INC.
Addresses
79 T.W. ALEXANDER DRIVE, 4401 RESEARCH COMMONS, SUITE 105, RESEARCH TRIANGLE PARK, NC 27709
450 WEST DRIVE CB #7295, CHAPEL HILL, NC 27599-7295
405 WEST DRIVE CB #7295, CHAPEL HILL, NC 27599-7295
Phone Numbers
919-740-0115
919-213-9836
919-966-9755
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2008
State Incorporated:
DELAWARE
Total Amount Raised:
$81,122,095.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2016-04-27
$50,000,000.00
$50,000,000.00
$0.00
Equity
4
2015-02-04
$16,511,994.00
$33,011,989.00
$16,499,995.00
Equity
3
2013-10-08
$12,597,221.00
$12,597,221.00
$0.00
Equity
2
2013-04-03
$1,249,996.00
$1,250,000.00
$4.00
Debt
1
2012-08-27
$762,884.00
$762,884.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
GUTCH
DIRECTOR
PETER
KOLCHINSKY
DIRECTOR
RA CAPITAL HEALTHCARE FUND II, L.P.
| RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD
| RA CAPITAL HEALTHCARE FUND LP
| CELLSCAPE CORP
| DICERNA PHARMACEUTICALS INC
| WAVE LIFE SCIENCES PTE LTD
| CALIMMUNE, INC.
| LANTOS TECHNOLOGIES, INC.
| G1 THERAPEUTICS, INC.
| SOJOURNIX, INC.
| ADEO HEALTH SCIENCE, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.
| RA CAPITAL NEXUS FUND, L.P.
| VAXESS TECHNOLOGIES, INC.
| ICOSAVAX, INC.
| ARS PHARMACEUTICALS, INC.
| FREENOME HOLDINGS, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.
| RA CAPITAL NEXUS FUND III, L.P.
| NATURE-S TOOLBOX, INC.
| RA CAPITAL PLANETARY HEALTH FUND, L.P.
| RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.
| TERRESTRIAL BIO, INC.
RON
LAUFER
DIRECTOR
THOMAS
K
LAUNDON
EXECUTIVE OFFICER
SETH
RUDNICK
DIRECTOR
CHRISTY
SHAFFER
DIRECTOR
CLINIPACE INC
| EVOAPP, INC.
| CLEARSIDE BIOMEDICAL, INC.
| G-ZERO THERAPEUTICS, INC.
| G1 THERAPEUTICS, INC.
| KINODYN, INC.
| SPYRYX BIOSCIENCES, INC.
| HATTERAS VENTURE PARTNERS V, LP
| GRAYBUG, INC.
| TREFOIL THERAPEUTICS, INC.
| GRAYBUG VISION, INC.
| ARTIZAN BIOSCIENCES, INC.
| PERFUSE THERAPEUTICS, INC.
| HATTERAS VENTURE PARTNERS VI, LP
| AER THERAPEUTICS, INC.
| HATTERAS VENTURE PARTNERS VII, LP
| HATTERAS OPPORTUNITY FUND I, LP
| HATTERAS CREATE SF SPV, LLC
NORMAN
SHARPLESS
DIRECTOR
TIMOTHY
SULLIVAN
DIRECTOR
VARIETAL DISTRIBUTION HOLDINGS LLC
| FIDELIS SECURITY SYSTEMS INC
| TILANA SYSTEMS CORP
| TRUE ULTIMATE STANDARDS EVERYWHERE, INC.
| ANCESTRY.COM INC.
| AGQUEST FINANCIAL SERVICES INC
| XERIS PHARMACEUTICALS INC
| SAGE PRODUCTS HOLDINGS, LLC
| HOME LAB, INC
| NPULSE TECHNOLOGIES, INC.
| COMPOUND HOLDINGS I, LLC
| MUSTANG INVESTMENT HOLDINGS L.P.
| MOLECULAR TEMPLATES, INC.
| 123 CAMINO CARMELITA LLC
| NEW ENGLAND INNOVATION CENTER, LLC
| KH ACQUISITION, LLC
| HC GROUP HOLDINGS I, LLC
| MDP HC HOLDINGS, LLC
| LANAI HOLDINGS I, LLC
| G1 THERAPEUTICS, INC.
| MDP ACM HOLDINGS, LLC
| SM HOLDCO, LLC
| ARCADIA LANDING LLC
| CAVEONIX INC.
| SURGICAL TRAINING SIMULATORS, INC.
CLAY
THORP
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
| CANCERGUIDE DIAGNOSTICS, INC.
| PATHFINDER THERAPEUTICS, INC.
| CLEARSIDE BIOMEDICAL, INC.
| G-ZERO THERAPEUTICS, INC.
| GENECENTRIC DIAGNOSTICS, INC.
| G1 THERAPEUTICS, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| ORIG3N, INC.
| STRIDEBIO, INC.
| GENECENTRIC THERAPEUTICS, INC.
| VIGIL NEUROSCIENCE, INC.
| PIPR THERAPEUTICS, INC.
CAROL
WEBB
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-04-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-04-27
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
